Robotic vs. Laparoscopic Cholecystectomy: Does Technology Translate Into Better Outcomes?

Cholecystectomy remains one of the most commonly performed surgical procedures worldwide. For decades, laparoscopic cholecystectomy has been the gold standard for treating benign gallbladder disease. However, with the rapid adoption of robotic surgery platforms, surgeons and patients alike are asking: Does the robotic approach actually improve outcomes compared with laparoscopy?

A recent large-scale analysis published in Surgery (DOI: 10.1016/j.surg.2024.08.006) provides timely evidence to address this

question.

---

Study Overview

• Design: Retrospective cohort study
• Data Source: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)
• Population: Patients undergoing cholecystectomy for benign indications in 2022
• Sample Size:59,216 patients
  • Laparoscopic: 53,746
  • Robotic: 5,470

---

Key Findings

1. Patient Demographics
   • Laparoscopic patients were slightly older (50.4 vs 49.7 years).
   • Higher proportion of males in laparoscopic group (32.7% vs 29.7%).
   • Laparoscopic group included more patients categorized as “other” races beyond White, African American, and Asian (28.6% vs 14.8%).
2. Surgical Outcomes
   After multivariable adjustment, robotic cholecystectomy showed:
   • Lower risk of serious complications (Clavien-Dindo grade III–IV)
     • OR 0.82; 95% CI 0.69–0.98
   • Lower conversion to open surgery
     • OR 0.44; 95% CI 0.32–0.61
   • Lower odds of prolonged hospitalization (≥24 hours)
     • OR 0.76; 95% CI 0.71–0.81
   However, there were no significant differences in:
   • Reoperation (OR 0.69; CI 0.47–1.00)
   • Readmission (OR 0.94; CI 0.82–1.10)

---

Interpretation

This study provides the strongest multicenter evidence to date suggesting that robotic cholecystectomy may confer incremental advantages over laparoscopy, particularly in:

• Reducing major complications
• Avoiding conversion to open surgery
• Minimizing prolonged hospitalization

The lack of difference in reoperation and readmission rates indicates that while robotic surgery might reduce intraoperative and immediate postoperative risks, long-term outcomes remain comparable.

---

Clinical Implications

1. Safety Advantage: Even a modest reduction in serious complications and open conversion is meaningful given the high global volume of cholecystectomies.
2. Patient Selection: Patients at higher risk for complications (e.g., obesity, prior abdominal surgery, dense adhesions) may particularly benefit from robotic precision.
3. Cost–Benefit Balance: The clinical gains must be weighed against higher costs, longer operative times, and institutional resource allocation.

---

Conclusion

The findings of this national study suggest that robotic cholecystectomy enhances the safety profile of minimally invasive gallbladder surgery, though improvements are incremental rather than revolutionary. For hospitals with established robotic programs, these results support its integration into routine cholecystectomy practice. However, whether these benefits justify the added financial burden remains a pressing question for health systems worldwide.

---

✅ Key Takeaway for Surgeons:
Robotic cholecystectomy is not merely “laparoscopy with fancy instruments.” It may provide tangible benefits in complication reduction and surgical safety, making it an evolving standard of care for selected patients.

source : https://www.sciencedirect.com/science/article/abs/pii/S0039606024005853